Lyceum
Curated by SignalAI-driven theoretical and experimental systems biology to understand disease and develop therapeutics
Overview
Lyceum is leveraging the research of evolutionary biologist, Michael Rose at the UC Irvine to create an AI-driven experimental and analytical framework to gain deep insights into aging and associated chronic diseases to find biomarkers and therapeutics. The company's primary tools include a large collection of Drosophila populations that are derived from natural outbred populations and can be used as disease models and novel statistical approaches to determining the most important genomic sites and pathways underlying chronic diseases. The company is partnering with BluePrint Bio, a biomarker discovery company, and Emerald Logic, which has developed a precision analytics platform for integrated multi-omic discovery.
Key facts
- Founded
- 2015
- Headquarters
- Los Angeles, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology